Ranjana Sood, MD
Rheumatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 3 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
16 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sood’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G80082 · Current
Licensed to practise in California · since 1994 · expires 2028-07-31 · Umdnj Robert Wood Johnson Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$33,032
Medicare paid this office $33,032 for 149 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 88 | $19,648 | $106 |
| Short return visit (20+ min) | 71 | $7,960 | $73 |
| New patient visit (45+ min) | 23 | $3,585 | $156 |
Who their Medicare patients are
149 Original Medicare patients in 2024. Average age 76 · Under 65 9% · 85 and older 20% · Women 75% · Also on Medicaid 16% · Health risk score 1.24. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 71% · Diabetes 26% · Chronic kidney disease 23% · Depression 20% · Coronary heart disease 15% · Cancer 15% · Atrial fibrillation 14% · COPD 10% · Heart failure 9% · Stroke 7%.
The office billed $118,457, Medicare allowed $47,444 and paid $33,032; for 534 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 149 | 534 | 76 | 1.24 | $118,457 | $33,032 |
| 2023 | 163 | 375 | 77 | 1.23 | $125,018 | $37,934 |
| 2022 | 171 | 496 | 77 | 1.32 | $116,025 | $35,700 |
| 2021 | 195 | 410 | 76 | 1.20 | $145,335 | $46,194 |
| 2020 | 177 | 400 | 76 | 1.45 | $125,510 | $36,823 |
| 2019 | 208 | 510 | 76 | 1.18 | $166,053 | $47,751 |
| 2018 | 222 | 523 | 75 | 1.09 | $165,530 | $46,571 |
| 2017 | 227 | 504 | 75 | 1.30 | $155,439 | $46,296 |
| 2016 | 198 | 467 | 74 | 1.12 | $149,355 | $43,932 |
| 2015 | 157 | 452 | 75 | 1.12 | $118,612 | $36,439 |
| 2014 | 157 | 346 | 75 | 1.24 | $103,923 | $30,947 |
| 2013 | 156 | 333 | 74 | 1.22 | $92,014 | $26,830 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 104 | $21,327 | $110 |
| Short return visit (20+ min) | 81 | $9,547 | $81 |
| New patient visit (45+ min) | 26 | $4,027 | $155 |
2022: 4 services
| Return visit (30+ min) | 114 | $21,585 | $112 |
| New patient visit (45+ min) | 37 | $5,520 | $149 |
| Short return visit (20+ min) | 46 | $4,239 | $83 |
| Long return visit (40+ min) | 19 | $2,626 | $138 |
2021: 4 services
| Return visit (30+ min) | 142 | $31,595 | $111 |
| New patient visit (45+ min) | 54 | $7,759 | $144 |
| Short return visit (20+ min) | 38 | $3,518 | $82 |
| Long return visit (40+ min) | 11 | $1,942 | $177 |
2020: 4 services
| Return visit (30+ min) | 124 | $24,193 | $91 |
| New patient visit (45+ min) | 44 | $6,537 | $149 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $1,855 | $74 |
| Short return visit (20+ min) | 21 | $1,416 | $64 |
2019: 4 services
| Return visit (30+ min) | 141 | $29,235 | $94 |
| New patient visit (45+ min) | 63 | $9,129 | $145 |
| Short return visit (20+ min) | 55 | $4,331 | $60 |
| Long return visit (40+ min) | 15 | $2,113 | $132 |
2018: 6 services
| Return visit (30+ min) | 158 | $28,298 | $90 |
| New patient visit (45+ min) | 69 | $9,817 | $142 |
| Short return visit (20+ min) | 47 | $3,463 | $61 |
| Long return visit (40+ min) | 12 | $1,555 | $130 |
| New patient visit (30+ min) | 11 | $1,118 | $102 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $85 | None |
2017: 7 services
| Return visit (30+ min) | 141 | $24,552 | $94 |
| New patient visit (45+ min) | 69 | $10,153 | $147 |
| Short return visit (20+ min) | 63 | $4,873 | $57 |
| Long return visit (40+ min) | 18 | $2,419 | $134 |
| New patient visit (30+ min) | 15 | $1,302 | $87 |
| Aspiration and/or injection of fluid from large joint | 12 | $675 | $52 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $94 | None |
2016: 6 services
| Return visit (30+ min) | 123 | $23,075 | $90 |
| New patient visit (45+ min) | 72 | $10,435 | $145 |
| Short return visit (20+ min) | 54 | $3,988 | $60 |
| New patient visit (60+ min) | 12 | $2,273 | $189 |
| Long return visit (40+ min) | 11 | $1,351 | $123 |
| New patient visit (30+ min) | 13 | $1,023 | $79 |
2015: 5 services
| Return visit (30+ min) | 110 | $20,862 | $98 |
| New patient visit (45+ min) | 42 | $6,474 | $154 |
| Short return visit (20+ min) | 45 | $4,285 | $60 |
| New patient visit (30+ min) | 14 | $1,239 | $88 |
| Injection, methylprednisolone acetate, 40 mg | 12 | $50 | None |
2014: 3 services
| Return visit (30+ min) | 95 | $14,033 | $94 |
| New patient visit (45+ min) | 56 | $8,234 | $147 |
| Short return visit (20+ min) | 69 | $5,870 | $58 |
2013: 4 services
| Return visit (30+ min) | 73 | $9,380 | $88 |
| Short return visit (20+ min) | 88 | $8,232 | $57 |
| New patient visit (45+ min) | 35 | $4,979 | $142 |
| New patient visit (30+ min) | 12 | $1,107 | $92 |
Drugs they prescribed that Part D paid
$1,454,949
Pharmacies billed $1,454,949 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
896 generic and fewer than 11 brand-name prescriptions · $1,454,949 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 46 | $307,058 | $6,675 |
| Enbrel Sureclick | 27 | $189,223 | $7,008 |
| Orencia Clickject | 25 | $164,885 | $6,595 |
| Humira | 16 | $153,792 | $9,612 |
| Actemra Actpen | 20 | $105,183 | $5,259 |
See all 19 drugs
| Humira(Cf) | 46 | $307,058 | $6,675 |
| Enbrel Sureclick | 27 | $189,223 | $7,008 |
| Orencia Clickject | 25 | $164,885 | $6,595 |
| Humira | 16 | $153,792 | $9,612 |
| Actemra Actpen | 20 | $105,183 | $5,259 |
| Otezla | 24 | $96,504 | $4,021 |
| Xeljanz Xr | 11 | $64,149 | $5,832 |
| Xeljanz | 11 | $61,772 | $5,616 |
| Methotrexate | 230 | $6,508 | $28 |
| Hydroxychloroquine Sulfate | 106 | $3,356 | $32 |
| Prednisone | 248 | $1,635 | $7 |
| Leflunomide | 16 | $1,362 | $85 |
| Allopurinol | 64 | $619 | $10 |
| Celecoxib | 13 | $424 | $33 |
| Colchicine | 15 | $407 | $27 |
| Folic Acid | 38 | $367 | $10 |
| Gabapentin | 20 | $222 | $11 |
| Alendronate | 34 | $134 | $4 |
| Escitalopram | 11 | $71 | $6 |
Year by year
| 2024 | 1,136 | 152 | None | None | $1,454,949 |
| 2023 | 1,002 | 141 | None | None | $1,286,007 |
| 2022 | 987 | 162 | None | None | $1,155,094 |
| 2021 | 1,041 | 148 | None | None | $1,270,267 |
| 2020 | 994 | 151 | None | None | $1,037,706 |
| 2019 | 963 | 140 | None | None | $597,695 |
| 2018 | 1,053 | 148 | 2% (17) | 15% | $521,081 |
| 2017 | 1,006 | 158 | 3% (25) | 16% | $445,280 |
| 2016 | 979 | 145 | 5% (51) | None | $327,666 |
| 2015 | 905 | 128 | 2% (15) | 18% | $258,809 |
| 2014 | 750 | 130 | 3% (23) | 17% | $138,478 |
| 2013 | 605 | 117 | 4% (22) | 20% | $74,996 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Humira(Cf) | 25 | $246,045 | $9,842 |
| Orencia Clickject | 29 | $218,941 | $7,550 |
| Enbrel Sureclick | 25 | $175,484 | $7,019 |
| Humira | 18 | $167,514 | $9,306 |
| Humira | 14 | $92,670 | $6,619 |
| Orencia | 13 | $75,842 | $5,834 |
| Otezla | 14 | $34,414 | $2,458 |
| Methotrexate | 188 | $8,630 | $46 |
| Hydroxychloroquine Sulfate | 111 | $4,846 | $44 |
| Prednisone | 234 | $2,519 | $11 |
| Leflunomide | 22 | $1,437 | $65 |
| Sulfasalazine | 12 | $542 | $45 |
| Allopurinol | 50 | $531 | $11 |
| Celecoxib | 17 | $407 | $24 |
| Gabapentin | 30 | $346 | $12 |
| Alendronate | 35 | $251 | $7 |
| Trazodone | 12 | $179 | $15 |
| Folic Acid | 29 | $112 | $4 |
2022: 18 drugs
| Humira(Cf) | 33 | $229,954 | $6,968 |
| Orencia Clickject | 32 | $211,826 | $6,620 |
| Humira | 21 | $190,487 | $9,071 |
| Enbrel Sureclick | 15 | $102,771 | $6,851 |
| Enbrel | 11 | $95,874 | $8,716 |
| Xeljanz | 11 | $55,554 | $5,050 |
| Otezla | 13 | $30,236 | $2,326 |
| Methotrexate | 189 | $12,196 | $65 |
| Otrexup | 13 | $9,620 | $740 |
| Hydroxychloroquine Sulfate | 116 | $9,055 | $78 |
| Prednisone | 239 | $3,194 | $13 |
| Leflunomide | 11 | $1,263 | $115 |
| Gabapentin | 28 | $645 | $23 |
| Celecoxib | 14 | $499 | $36 |
| Allopurinol | 24 | $380 | $16 |
| Alendronate | 44 | $250 | $6 |
| Folic Acid | 37 | $205 | $6 |
| Trazodone | 12 | $57 | $5 |
2021: 17 drugs
| Humira(Cf) | 50 | $297,497 | $5,950 |
| Humira | 27 | $229,523 | $8,501 |
| Orencia Clickject | 35 | $189,293 | $5,408 |
| Enbrel Sureclick | 16 | $103,287 | $6,455 |
| Actemra Actpen | 16 | $70,472 | $4,405 |
| Humira | 12 | $69,135 | $5,761 |
| Xeljanz | 12 | $57,445 | $4,787 |
| Methotrexate | 176 | $11,477 | $65 |
| Hydroxychloroquine Sulfate | 112 | $11,138 | $99 |
| Otrexup | 11 | $7,591 | $690 |
| Prednisone | 276 | $3,841 | $14 |
| Gabapentin | 36 | $939 | $26 |
| Celecoxib | 22 | $854 | $39 |
| Sulfasalazine | 15 | $649 | $43 |
| Allopurinol | 21 | $415 | $20 |
| Alendronate | 56 | $304 | $5 |
| Folic Acid | 26 | $120 | $5 |
2020: 16 drugs
| Humira(Cf) | 50 | $370,204 | $7,404 |
| Orencia Clickject | 35 | $182,275 | $5,208 |
| Humira | 16 | $173,077 | $10,817 |
| Humira | 11 | $59,348 | $5,395 |
| Xeljanz | 12 | $54,762 | $4,564 |
| Hydroxychloroquine Sulfate | 112 | $11,280 | $101 |
| Methotrexate | 181 | $10,698 | $59 |
| Prednisone | 285 | $3,553 | $12 |
| Mycophenolate Mofetil | 12 | $1,937 | $161 |
| Leflunomide | 11 | $1,015 | $92 |
| Celecoxib | 24 | $754 | $31 |
| Gabapentin | 27 | $716 | $27 |
| Diclofenac | 22 | $561 | $25 |
| Allopurinol | 20 | $374 | $19 |
| Leucovorin | 13 | $319 | $25 |
| Alendronate | 51 | $228 | $4 |
2019: 13 drugs
| Humira | 21 | $137,142 | $6,531 |
| Humira(Cf) | 21 | $114,376 | $5,446 |
| Xeljanz Xr | 17 | $78,231 | $4,602 |
| Xeljanz | 12 | $52,205 | $4,350 |
| Hydroxychloroquine Sulfate | 109 | $12,843 | $118 |
| Methotrexate | 218 | $11,554 | $53 |
| Prednisone | 322 | $3,986 | $12 |
| Sulfasalazine | 11 | $602 | $55 |
| Celecoxib | 11 | $574 | $52 |
| Allopurinol | 38 | $459 | $12 |
| Diclofenac | 14 | $424 | $30 |
| Alendronate | 47 | $274 | $6 |
| Leucovorin | 11 | $186 | $17 |
2018: 14 drugs
| Humira | 33 | $169,482 | $5,136 |
| Xeljanz Xr | 16 | $65,635 | $4,102 |
| Humira | 13 | $61,495 | $4,730 |
| Xeljanz | 12 | $47,720 | $3,977 |
| Rayos | 13 | $41,214 | $3,170 |
| Hydroxychloroquine Sulfate | 118 | $15,901 | $135 |
| Methotrexate | 201 | $14,559 | $72 |
| Prednisone | 352 | $4,125 | $12 |
| Gabapentin | 32 | $926 | $29 |
| Allopurinol | 50 | $789 | $16 |
| Celecoxib | 11 | $725 | $66 |
| Sulfasalazine | 15 | $678 | $45 |
| Hydrocodone-Acetaminophen | 13 | $400 | $31 |
| Alendronate | 72 | $337 | $5 |
2017: 13 drugs
| Humira | 27 | $122,477 | $4,536 |
| Xeljanz Xr | 17 | $64,045 | $3,767 |
| Xeljanz | 11 | $41,322 | $3,757 |
| Hydroxychloroquine Sulfate | 95 | $14,425 | $152 |
| Methotrexate | 192 | $12,100 | $63 |
| Prednisone | 315 | $3,885 | $12 |
| Celecoxib | 12 | $767 | $64 |
| Sulfasalazine | 24 | $699 | $29 |
| Allopurinol | 39 | $612 | $16 |
| Alendronate | 86 | $472 | $5 |
| Gabapentin | 28 | $226 | $8 |
| Tramadol | 16 | $130 | $8 |
| Trazodone | 14 | $100 | $7 |
2016: 15 drugs
| Simponi | 11 | $64,226 | $5,839 |
| Xeljanz | 18 | $61,474 | $3,415 |
| Humira | 12 | $49,211 | $4,101 |
| Hydroxychloroquine Sulfate | 92 | $12,480 | $136 |
| Uloric | 12 | $8,049 | $671 |
| Methotrexate | 147 | $7,983 | $54 |
| Prednisone | 331 | $4,331 | $13 |
| Gabapentin | 11 | $745 | $68 |
| Hydrocodone-Acetaminophen | 27 | $644 | $24 |
| Sulfasalazine | 18 | $558 | $31 |
| Alendronate | 95 | $546 | $6 |
| Allopurinol | 31 | $507 | $16 |
| Trazodone | 40 | $266 | $7 |
| Tramadol | 21 | $218 | $10 |
| Ibuprofen | 11 | $126 | $11 |
2015: 14 drugs
| Simponi | 13 | $70,422 | $5,417 |
| Enbrel | 11 | $46,719 | $4,247 |
| Humira | 14 | $45,856 | $3,275 |
| Hydroxychloroquine Sulfate | 103 | $15,608 | $152 |
| Uloric | 14 | $8,940 | $639 |
| Methotrexate | 110 | $8,424 | $77 |
| Prednisone | 323 | $4,513 | $14 |
| Celecoxib | 13 | $743 | $57 |
| Allopurinol | 37 | $620 | $17 |
| Alendronate | 77 | $519 | $7 |
| Gabapentin | 16 | $330 | $21 |
| Valacyclovir | 12 | $227 | $19 |
| Ibuprofen | 12 | $136 | $11 |
| Trazodone | 16 | $67 | $4 |
2014: 9 drugs
| Humira | 28 | $75,211 | $2,686 |
| Uloric | 20 | $7,872 | $394 |
| Methotrexate | 78 | $7,793 | $100 |
| Colcrys | 21 | $7,274 | $346 |
| Prednisone | 247 | $3,734 | $15 |
| Hydroxychloroquine Sulfate | 108 | $2,196 | $20 |
| Allopurinol | 44 | $344 | $8 |
| Alendronate | 43 | $290 | $7 |
| Hydrocodone-Acetaminophen | 12 | $263 | $22 |
2013: 11 drugs
| Humira | 20 | $42,885 | $2,144 |
| Colcrys | 26 | $8,606 | $331 |
| Methotrexate | 84 | $6,160 | $73 |
| Uloric | 16 | $4,712 | $295 |
| Prednisone | 193 | $2,529 | $13 |
| Hydroxychloroquine Sulfate | 58 | $1,486 | $26 |
| Alendronate | 55 | $483 | $9 |
| Allopurinol | 33 | $338 | $10 |
| Hydrocodone-Acetaminophen | 11 | $233 | $21 |
| Tramadol | 11 | $149 | $14 |
| Folic Acid | 11 | $31 | $3 |
Money from drug and device companies
$1,024 in 2025
| 2025 | 5 | 15 | None | $1,024 |
| 2024 | 4 | 8 | None | $906 |
| 2023 | 5 | 6 | None | $400 |
| 2022 | 6 | 22 | None | $597 |
| 2021 | 1 | 3 | None | $65 |
| 2019 | 5 | 19 | None | $1,105 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $488 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $275 | 8 payments
|
| Ucb | Bimzelx | $125 | 1 payment
|
| Sanofi-Aventis U.S. | Kevzara | $100 | 1 payment
|
| Amgen | Tavneos | $36 | 1 payment
|
See all 15 published payments
| Amgen | Meals · 2025-12-16 | Tavneos | $36 |
| Abbvie | Meals · 2025-11-20 | Skyrizi | $122 |
| Novartis Pharmaceuticals | Meals · 2025-10-24 | Cosentyx | $23 |
| Novartis Pharmaceuticals | Meals · 2025-09-12 | Cosentyx | $58 |
| Novartis Pharmaceuticals | Meals · 2025-09-11 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-19 | Cosentyx | $21 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Cosentyx | $15 |
| Abbvie | Meals · 2025-06-19 | Rinvoq | $122 |
| Novartis Pharmaceuticals | Meals · 2025-06-06 | Cosentyx | $27 |
| Novartis Pharmaceuticals | Meals · 2025-05-01 | Cosentyx | $99 |
| Sanofi-Aventis U.S. | Education · 2025-05-01 | Kevzara | $100 |
| Ucb | Meals · 2025-04-17 | Bimzelx | $125 |
| Abbvie | Meals · 2025-04-10 | None | $124 |
| Novartis Pharmaceuticals | Meals · 2025-03-12 | Cosentyx | $17 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $119 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $906
| Abbvie | Rinvoq | $447 | 4 payments
|
| Ucb | Bimzelx | $205 | 2 payments
|
| Janssen Biotech | Tremfya | $129 | 1 payment
|
| Amgen | Tavneos | $125 | 1 payment
|
2023: $400
| AstraZeneca Pharmaceuticals LP | Saphnelo | $125 | 1 payment
|
| Ucb | Cimzia | $125 | 1 payment
|
| AbbVie | Rinvoq | $86 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $46 | 2 payments
|
| Janssen Biotech | Tremfya | $18 | 1 payment
|
2022: $597
| Janssen Biotech | Tremfya | $186 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $136 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $125 | 8 payments
|
| Ucb | None | $88 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $45 | 1 payment
|
| Abbvie | Rinvoq | $17 | 1 payment
|
2021: $65
| Janssen Biotech | Tremfya | $65 | 3 payments
|
2019: $1,105
| AbbVie | Humira | $444 | 11 payments
|
| Amgen | Enbrel | $250 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $168 | 4 payments
|
| Ucb | None | $124 | 1 payment
|
| Pfizer | Xeljanz | $120 | 1 payment
|
Professional record
- NPI
- 1548325335
- Licence
- CA G80082California G80082: Current · expires 2028-07-31
- Trained
- Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 1990
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 2350 W El Camino Real, Mountain View, CA, 94040
- NPI first listed
- 2006-12-22
- NPI last updated
- 2011-12-05
This is when the NPI record was last certified, not a medical board exam.